Catheter Precision, Inc. - יחס מהיר VTAK

The VIVO 3D mapping ecosystem ensures full clinic loyalty and rapid operational growth, as reflected by the market's real-time valuation of Catheter Precision (VTAK) at 0.18. The business relies on highly skilled biomedical specialists attracted by the prestige of innovation. High profitability is achieved through proprietary equipment for the mass production of catheters, allowing the company to scale sales volumes without a significant increase in operating expenses.

Developing navigation systems for electrophysiology laboratories requires high operational flexibility from Catheter Precision. This metric is calculated by dividing the sum of cash and accounts receivable by current liabilities, completely excluding inventory. Such strict filtering reveals the company's actual ability to settle debts without an emergency fire sale of equipment. By analyzing this snapshot of quick liquidity, an investor assesses the balance between financial security and capital efficiency.